Douglas M. Hunt - Mar 3, 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Signature
/s/ Douglas M. Hunt
Stock symbol
PBYI
Transactions as of
Mar 3, 2022
Transactions value $
$0
Form type
4
Date filed
3/14/2022, 07:43 PM
Previous filing
Mar 4, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBYI Common Stock Award $0 +22.6K +37.68% $0.00 82.8K Mar 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBYI Stock Option (Right to Buy) Award $0 +32.4K $0.00 32.4K Mar 3, 2022 Common Stock 32.4K $2.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
F2 Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.

Remarks:

The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.